Navigation Links
Myriant Technologies, Inc. Announces J. Brian Ferguson to Join Advisory Board
Date:3/2/2011

QUINCY, Mass., March 2, 2011 /PRNewswire/ -- Myriant Technologies, Inc. (Myriant), a privately-held, biotech developer and manufacturer of renewable bio-based chemicals, announces the addition of J. Brian Ferguson to its Board of Advisors effective immediately.  Mr. Ferguson, 56, is the former CEO and Chairman of Eastman Chemical Company, a global chemical company engaged in the manufacture and sale of a broad portfolio of chemicals, plastics and fibers.  

(Logo: http://photos.prnewswire.com/prnh/20091021/NE96331LOGO)

"I am honored and excited to have Brian Ferguson join our Board of Advisors.  Between his tenure as CEO of Eastman and chairmanship of the American Chemistry Council, it is hard to imagine someone with a stronger grasp of the issues and influences surrounding our business," said Stephen J. Gatto, Chairman and Chief Executive Officer of Myriant.  "We look forward to Mr. Ferguson bringing his wealth of experience and global understanding of the business to Myriant as we transform the chemical markets with our bio-based platform."

"Myriant is an exciting young company that is shaping the new chemical industry landscape by creating the products and processes of the future," said Mr. Ferguson.  "I'm very happy to have a part in this visionary leadership and Myriant's continuing achievements in bio-based chemicals."

Mr. Ferguson served as CEO and Chairman of Eastman from January of 2002 through June of 2008, and as Executive Chairman of the Board from June 2008 through December 2010.  Prior to his roles as CEO/Chairman, Mr. Ferguson was President of Eastman's Chemicals Group where he had direct responsibility for all chemicals-based business organizations, as well as the manufacturing, sales, pricing and product management, technology and geographical aspects of the business group.

Mr. Ferguson has served as a director of Nextera Energy, Inc. (formerly FPL Group) since 2005.  He was Chairman of the American Chemistry Council in 2010, and was a member of the Business Roundtable and the board of the National Association of Manufacturers prior to his retirement from Eastman.  

Mr. Ferguson joins existing Advisory Board members Norman R. Augustine, Robert McFarlane and Chairman R. James Woolsey. Myriant's Advisory Board advises the company's Board of Directors and management in the Company's strategic decision making process and other matters including business and organizational development, technology, policy and outreach.

With a world-renowned team of molecular biologists, engineers and chemists, Myriant utilizes proprietary technology to advance the development of low-cost cellulosic sugars for the sustainable commercialization of high-value specialty chemicals.  The company's D(-) lactic acid started production at commercial scale in June 2008 for use in polylactic acid. Myriant is headquartered in Quincy, Massachusetts. Details are available at www.myriant.com.Contacts:Myriant - Samuel G. McConnell, Sr.VP, Corporate DevelopmentTelephone:  (617) 657-5207  Email: smcconnell@myriant.com
'/>"/>

SOURCE Myriant Technologies, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. Myriant Technologies, Inc. Announces US$60 Million Strategic Equity Investment From PTT Chemical Group
2. Gov. Jindal Announces Myriant Technologies to Begin Construction of New, Sustainable Specialty Chemical Plant in Lake Providence
3. Myriant Technologies LLC Selected for $50 Million Award for Succinic Acid Biorefinery Project
4. Myriant Technologies LLC, Uhde Corporation of America and Uhde GmbH Announce Alliance for Engineering, Procurement & Construction of World Scale Renewable Succinic Acid Plants
5. Myriant Technologies LLC Announces Appointment of Science Advisory Board Members
6. BioEnergy International, LLC Announces Formation of Myriant Technologies LLC
7. Palatin Technologies, Inc. Announces Pricing of Public Offering of Common Stock and Warrants
8. Palatin Technologies, Inc. Announces Proposed Public Offering of Common Stock and Warrants
9. Palatin Technologies, Inc. December 31, 2010 Quarter Results; Teleconference and Webcast to be Held on February 24, 2011
10. AMDeCs Vendor Program Expands Focus with Addition of BioStorage Technologies, Offering Preferred Pricing on Tissue Storage and Cold Chain Logistics Services
11. Palatin Technologies, Inc. Reports Second Quarter Fiscal Year 2011 Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/11/2017)... ... October 11, 2017 , ... At its national board ... Suneel I. Sheikh, the co-founder, CEO and chief research scientist of Minnesota-based Advanced ... for membership in ARCS Alumni Hall of Fame . ASTER Labs is ...
(Date:10/11/2017)... Alto, CA, USA (PRWEB) , ... October 11, 2017 , ... ... set to take place on 7th and 8th June 2018 in San Francisco, CA. ... policy influencers as well as several distinguished CEOs, board directors and government officials from ...
(Date:10/11/2017)... the Netherlands and LAGUNA HILLS, Calif. ... The Institute of Cancer Research, London ... use MMprofilerâ„¢ with SKY92, SkylineDx,s prognostic tool to risk-stratify patients ... trial known as MUK nine . The University of ... trial, which is partly funded by Myeloma UK, and ICR ...
(Date:10/11/2017)... (PRWEB) , ... October 11, 2017 , ... ... Administration (FDA) has granted orphan drug designation to SBT-100, its novel anti-STAT3 (Signal ... the treatment of osteosarcoma. SBT-100 is able to cross the cell membrane and ...
Breaking Biology Technology:
(Date:4/3/2017)...  Data captured by IsoCode, IsoPlexis Corporation,s ... statistically significant association between the potency of ... objective response of cancer patients post-treatment. The ... cancer patients will respond to CAR-T cell ... to improve both pre-infusion potency testing and cell ...
(Date:3/29/2017)... 29, 2017  higi, the health IT company that ... North America , today announced a Series B ... of EveryMove. The new investment and acquisition accelerates higi,s ... to transform population health activities through the collection and ... higi collects and secures data today on behalf ...
(Date:3/24/2017)... 2017 Research and Markets has announced the ... & Trends - Industry Forecast to 2025" report to their ... The Global ... CAGR of around 15.1% over the next decade to reach approximately ... the market estimates and forecasts for all the given segments on ...
Breaking Biology News(10 mins):